NCT01469182View on ClinicalTrials.gov

A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751)

PHASE3CompletedINTERVENTIONAL
Enrollment

914

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

April 30, 2012

Study Completion Date

April 30, 2012

Conditions
Allergy
Interventions
BIOLOGICAL

SCH 39641

Rapidly dissolving tablet sublingually once daily

DRUG

Placebo for SCH 39641

Rapidly dissolving tablet sublingually once daily

All Listed Sponsors
lead

ALK-Abelló A/S

INDUSTRY

NCT01469182 - A Study of Ragweed (Ambrosia Artemisiifolia) Allergy Immunotherapy Tablet in Adults With Ragweed Allergies (P05751) | Biotech Hunter | Biotech Hunter